Skip to main content

Advertisement

Log in

Hemostatic and hemorrhagic problems in neurosurgical patients

  • Review Article
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Abnormalities of the hemostasis can lead to hemorrhage, and on the other hand to thrombosis. Intracranial neoplasms, complex surgical procedures, and head injury have a specific impact on coagulation and fibrinolysis. Moreover, the number of neurosurgical patients on medication (which interferes with platelet function and/or the coagulation systems) has increased over the past years.

Method

The objective of this review is to recall common hemostatic disorders in neurosurgical patients on the basis of the “new concept of hemostasis”. Therefore the pertinent literature was searched to provide a structured and up to date manuscript about hemostasis in Neurosurgery.

Findings

According to recent scientific publications abnormalities of the coagulation system are discussed. Pathophysiological background and the rational for specific (cost)-effective perioperative hemostatic therapy is provided.

Conclusions

Perturbations of hemostasis can be multifactorial and maybe encountered in the daily practice of neurosurgery. Early diagnosis and specific treatment is the prerequisite for successful treatment and good patients outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Abrahams JM, Torchia MB, McGarvey M, Putt M, Baranov D, Sinson GP (2002) Perioperative assessment of coagulability in neurosurgical patients using thromboelastography. Surg Neurol 58:5–11

    PubMed  Google Scholar 

  2. Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D’Angelo A, Beltrametti C, Damiani M, Andrioli GC, Pugliese R, Iorio A, Brambilla G (1998) Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339:80–85

    PubMed  CAS  Google Scholar 

  3. Albanese A, Tuttolomondo A, Anile C, Sabatino G, Pompucci A, Pinto A, Licata G, Mangiola A (2005) Spontaneous chronic subdural hematomas in young adults with a deficiency in coagulation factor XIII. Report of three cases. J Neurosurg 102:1130–1132

    PubMed  Google Scholar 

  4. Aldouri M (2002) The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 32(Suppl 1):41–46

    PubMed  CAS  Google Scholar 

  5. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W (2006) An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 16:31–39

    PubMed  CAS  Google Scholar 

  6. Arai Y, Kubota T, Nakagawa T, Kabuto M, Sato K, Kobayashi H (1998) Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours. Acta Neurochir (Wien) 140:377–385

    CAS  Google Scholar 

  7. Astrup T (1965) Assay and content of tissue thromboplastin in different organs. Thromb Diath Haemorrh 14:401–416

    PubMed  CAS  Google Scholar 

  8. Auguste KI, Quinones-Hinojosa A, Berger MS (2004) Efficacy of mechanical prophylaxis for venous thromboembolism in patients with brain tumors. Neurosurg Focus 17:E3

    PubMed  Google Scholar 

  9. Auguste KI, Quinones-Hinojosa A, Gadkary C, Zada G, Lamborn KR, Berger MS (2003) Incidence of venous thromboembolism in patients undergoing craniotomy and motor mapping for glioma without intraoperative mechanical prophylaxis to the contralateral leg. J Neurosurg 99:680–684

    PubMed  Google Scholar 

  10. Baglin TP, Keeling DM, Watson HG (2006) Guidelines on oral anticoagulation (warfarin): third edition–2005 update. Br J Haematol 132:277–285

    PubMed  CAS  Google Scholar 

  11. Barnett HG, Clifford JR, Llewellyn RC (1977) Safety of mini-dose heparin administration for neurosurgical patients. J Neurosurg 47:27–30

    PubMed  CAS  Google Scholar 

  12. bdel-Wahab OI, Healy B, Dzik WH (2006) Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 46:1279–1285

    Google Scholar 

  13. Becker S, Schneider W, Kreuz W, Jacobi G, Scharrer I, Nowak-Gottl U (1999) Post-trauma coagulation and fibrinolysis in children suffering from severe cerebro-cranial trauma. Eur J Pediatr 158(Suppl 3):S197–S202

    PubMed  Google Scholar 

  14. Benzer H, Blümel G, Brenner H (1963) Ueber Blutgerinnungsstörungen nach Hirnverletzungen und Hirnverletzungen. Wien Klin Wochenschr 75:725–726

    PubMed  CAS  Google Scholar 

  15. Berger MM, Ravussin P, Vielle G, Fankhauser H (1995) Life-threatening hemorrhagic diathesis due to disseminated intravascular coagulation during elective brain tumor surgery. J Neurosurg Anesthesiol 7:26–29

    PubMed  CAS  Google Scholar 

  16. Bernstein DE, Jeffers L, Erhardtsen E, Reddy KR, Glazer S, Squiban P, Bech R, Hedner U, Schiff ER (1997) Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 113:1930–1937

    PubMed  CAS  Google Scholar 

  17. Black PM, Baker MF, Snook CP (1986) Experience with external pneumatic calf compression in neurology and neurosurgery. Neurosurgery 18:440–444

    PubMed  CAS  Google Scholar 

  18. Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y (2005) Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59:8–15

    PubMed  CAS  Google Scholar 

  19. Bohrer H (1999) Prothrombin complex concentrate substitution during liver transplantation. Thromb Res 95:S71–S74

    PubMed  CAS  Google Scholar 

  20. Bonnemaison J, Thicoipe M, Dixmerias F, Guerin V (1998) Coagulopathy suggestive of a primary fibrinolysis after head injuries with brain death. Ann Fr Anesth Reanim 17:275–277

    PubMed  CAS  Google Scholar 

  21. Bostrom S, Holmgren E, Jonsson O, Lindberg S, Lindstrom B, Winso I, Zachrisson B (1986) Post-operative thromboembolism in neurosurgery. A study on the prophylactic effect of calf muscle stimulation plus dextran compared to low-dose heparin. Acta Neurochir (Wien) 80:83–89

    CAS  Google Scholar 

  22. Boulis NM, Bobek MP, Schmaier A, Hoff JT (1999) Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 45:1113–1118

    PubMed  CAS  Google Scholar 

  23. Bratton SL, Chestnut RM, Ghajar J, Connell Hammond FF, Harris OA, Hartl R, Manley GT, Nemecek A, Newell DW, Rosenthal G, Schouten J, Shutter L, Timmons SD, Ullman JS, Videtta W, Wilberger JE, Wright DW (2007) Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis. J Neurotrauma 24(Suppl 1):S32–S36

    PubMed  Google Scholar 

  24. Brody DL, Aiyagari V, Shackleford AM, Diringer MN (2005) Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2:263–267

    PubMed  Google Scholar 

  25. Brohi K, Cohen MJ, Davenport RA (2007) Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 13:680–685

    PubMed  Google Scholar 

  26. Browd SR, Ragel BT, Davis GE, Scott AM, Skalabrin EJ, Couldwell WT (2004) Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature. Neurosurg Focus 17:E1

    PubMed  Google Scholar 

  27. Brown JR, Birkmeyer NJ, O’Connor GT (2007) Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 115:2801–2813

    PubMed  CAS  Google Scholar 

  28. Brozna JP (1990) Cellular regulation of tissue factor. Blood Coagul Fibrinolysis 1:415–426

    PubMed  CAS  Google Scholar 

  29. Brummel-Ziedins K, Whelihan MF, Ziedins EG, Mann KG (2006) The resuscitative fluid you choose may potentiate bleeding. J Trauma 61:1350–1358

    PubMed  Google Scholar 

  30. Bucci MN, Papadopoulos SM, Chen JC, Campbell JA, Hoff JT (1989) Mechanical prophylaxis of venous thrombosis in patients undergoing craniotomy: a randomized trial. Surg Neurol 32:285–288

    PubMed  CAS  Google Scholar 

  31. Bullock MR, Chesnut R, Ghajar J, Gordon D, Hartl R, Newell DW, Servadei F, Walters BC, Wilberger J (2006) Surgical management of traumatic parenchymal lesions. Neurosurgery 58:S25–S46

    PubMed  Google Scholar 

  32. Bullock MR, Chesnut R, Ghajar J, Gordon D, Hartl R, Newell DW, Servadei F, Walters BC, Wilberger JE (2006) Surgical management of acute epidural hematomas. Neurosurgery 58:S7–15

    PubMed  Google Scholar 

  33. Bullock R, Hanemann CO, Murray L, Teasdale GM (1990) Recurrent hematomas following craniotomy for traumatic intracranial mass. J Neurosurg 72:9–14

    PubMed  CAS  Google Scholar 

  34. Cannizzaro E, Albisetti M, Wohlrab G, Schmugge M (2007) Severe bleeding complications during antiepileptic treatment with valproic acid in children. Neuropediatrics 38:42–45

    PubMed  CAS  Google Scholar 

  35. Carrick MM, Tyroch AH, Youens CA, Handley T (2005) Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: support for serial laboratory examination. J Trauma 58:725–729

    PubMed  Google Scholar 

  36. Casbard AC, Williamson LM, Murphy MF, Rege K, Johnson T (2004) The role of prophylactic fresh-frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review. Anaesthesia 59:550–558

    PubMed  CAS  Google Scholar 

  37. Cermelj M, Negro F, Schijman E, Ferro AM, Acerenza M, Pollola J (2004) Neurosurgical intervention in a haemophilic child with a subdural and intracerebral haematoma. Haemophilia 10:405–407

    PubMed  CAS  Google Scholar 

  38. Cerrato D, Ariano C, Fiacchino F (1978) Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg 49:378–381

    PubMed  CAS  Google Scholar 

  39. Chan KH, Mann KS, Chan TK (1989) The significance of thrombocytopenia in the development of postoperative intracranial hematoma. J Neurosurg 71:38–41

    PubMed  CAS  Google Scholar 

  40. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, Sibony O, Mahieu-Caputo D, Hurtaud-Roux MF, Huisse MG, Denninger MH, de PD (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5:266–273

    PubMed  CAS  Google Scholar 

  41. Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW (2004) Efficacy of standard dose and 30 ml/kg fresh-frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125:69–73

    PubMed  Google Scholar 

  42. Churliaev IuA, Lychev VG, Epifantseva NN, Redkokasha LIu (1999) [Clinico-pathogenetic variants of DIC syndrome in patients with severe craniocerebral trauma]. Anesteziol Reanimatol (6):27–29

  43. Claes Y, Van Hemelrijck J, Van Gerven M, Arnout J, Vermylen J, Weidler B, Van Aken H (1992) Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. Anesth Analg 75:24–30

    PubMed  CAS  Google Scholar 

  44. Cohen MJ, Brohi K, Ganter MT, Manley GT, Mackersie RC, Pittet JF (2007) Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway. J Trauma 63:1254–1261

    PubMed  CAS  Google Scholar 

  45. Conroy JM, Fishman RL, Reeves ST, Pinosky ML, Lazarchick J (1996) The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg 83:804–807

    PubMed  CAS  Google Scholar 

  46. Contreras M (1998) Consensus conference on platelet transfusion. Final statement. Transfus Sci 19:111–114

    PubMed  CAS  Google Scholar 

  47. Cothren CC, Smith WR, Moore EE, Morgan SJ (2007) Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg 31:98–104

    PubMed  Google Scholar 

  48. Cravens GT, Brown MJ, Brown DR, Wass CT (2006) Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: Postoperative visual color changes after tranexamic acid administration. Anesthesiology 105:1274–1276

    PubMed  Google Scholar 

  49. Cronberg S, Wallmark E, Soderberg I (1984) Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand J Haematol 33:155–159

    PubMed  CAS  Google Scholar 

  50. Da’as N, Misgav M, Kalish Y, Varon D (2006) Recombinant factor VIIa for rapid reversal of anticoagulant effect in patients with intracranial hemorrhage: the Israeli experience and review of the literature. Isr Med Assoc J 8:807–811

    PubMed  Google Scholar 

  51. Dara SI, Rana R, Afessa B, Moore SB, Gajic O (2005) Fresh-frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 33:2667–2671

    PubMed  Google Scholar 

  52. Dasta JF, McLaughlin TP, Mody SH, Piech CT (2005) Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med 33:1266–1271

    PubMed  Google Scholar 

  53. de Jonge E, Levi M, Buller HR, Berends F, Kesecioglu J (2001) Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. Intensive Care Med 27:1825–1829

    PubMed  Google Scholar 

  54. Deloughery TG (2004) Coagulation defects in trauma patients: etiology, recognition, and therapy. Crit Care Clin 20:13–24

    PubMed  Google Scholar 

  55. Despotis GJ, Goodnough LT (2000) Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg 70:S20–S32

    PubMed  CAS  Google Scholar 

  56. Deveras RA, Kessler CM (2002) Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 137:884–888

    PubMed  CAS  Google Scholar 

  57. Dickinson LD, Miller LD, Patel CP, Gupta SK (1998) Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 43:1074–1081

    PubMed  CAS  Google Scholar 

  58. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, Broderick JP (2008) Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage. Stroke 39:850–856

    PubMed  CAS  Google Scholar 

  59. Dirkmann D, Hanke AA, Gorlinger K, Peters J (2008) Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg 106:1627–1632

    PubMed  Google Scholar 

  60. Donmez A, Turker H, Sekerci S, Kayhan Z, Ozbek N (1999) Dealing with a hemophilia-A patient undergoing cerebral aneurysm surgery. J Neurosurg Anesthesiol 11:214–215

    PubMed  CAS  Google Scholar 

  61. Doughty HA, Coles J, Parmar K, Bullock P, Savidge GF (1995) The successful removal of a bleeding intracranial tumour in a severe haemophiliac using an adjusted dose continuous infusion of monoclonal factor VIII. Blood Coagul Fibrinolysis 6:31–34

    PubMed  CAS  Google Scholar 

  62. Doughty HA, Northeast A, Sklair L, Roques T, Young AE, Savidge GF, Hunt BJ (1995) The use of recombinant factor VIIa in a patient with acquired haemophilia A undergoing surgery. Blood Coagul Fibrinolysis 6:125–128

    PubMed  CAS  Google Scholar 

  63. Drews RE (2003) Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med 24:607–622

    PubMed  Google Scholar 

  64. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U, Nashef SA (2008) Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34:73–92

    PubMed  Google Scholar 

  65. Durham SR, Liu KC, Selden NR (2006) Utility of serial computed tomography imaging in pediatric patients with head trauma. J Neurosurg 105:365–369

    PubMed  Google Scholar 

  66. Dutton RP, McCunn M, Hyder M, D'Angelo M, O'Connor J, Hess JR, Scalea TM (2004) Factor VIIa for correction of traumatic coagulopathy. J Trauma 57:709–718

    PubMed  CAS  Google Scholar 

  67. Dzik WH (2004) Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 3:324–330

    PubMed  Google Scholar 

  68. Earnshaw SR, Joshi AV, Wilson MR, Rosand J (2006) Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke 37:2751–2758

    PubMed  Google Scholar 

  69. Edwards RL, Rickles FR (1992) The role of leukocytes in the activation of blood coagulation. Semin Hematol 29:202–212

    PubMed  CAS  Google Scholar 

  70. Epstein NE (2005) A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery. Surg Neurol 64:295–301

    PubMed  Google Scholar 

  71. Etemadrezaie H, Baharvahdat H, Shariati Z, Lari SM, Shakeri MT, Ganjeifar B (2007) The effect of fresh-frozen plasma in severe closed head injury. Clin Neurol Neurosurg 109:166–171

    PubMed  Google Scholar 

  72. Evans G, Luddington R, Baglin T (2001) Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol 115:998–1001

    PubMed  CAS  Google Scholar 

  73. Federici AB (2005) Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys. Blood Coagul Fibrinolysis 16(Suppl 1):S17–S21

    PubMed  CAS  Google Scholar 

  74. Fenger-Eriksen C, Ingerslev J, Tønnesen E, Sørensen B (2009) Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy. Ann Hematol 88(3):255–260

    Google Scholar 

  75. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussieres JS, Cote D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358:2319–2331

    PubMed  CAS  Google Scholar 

  76. Fewel ME, Park P (2004) The emerging role of recombinant-activated factor VII in neurocritical care. Neurocrit Care 1:19–29

    PubMed  CAS  Google Scholar 

  77. Flinn WR, Sandager GP, Silva MB Jr, Benjamin ME, Cerullo LJ, Taylor M (1996) Prospective surveillance for perioperative venous thrombosis. Experience in 2,643 patients. Arch Surg 131:472–480

    PubMed  CAS  Google Scholar 

  78. Franchini M (2007) The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 82:731–735

    PubMed  CAS  Google Scholar 

  79. Fredriksson K, Norrving B, Stromblad LG (1992) Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 23:972–977

    PubMed  CAS  Google Scholar 

  80. Freeman WD, Brott TG, Barrett KM, Castillo PR, Deen HG Jr, Czervionke LF, Meschia JF (2004) Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 79:1495–1500

    PubMed  CAS  Google Scholar 

  81. Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, Wagner-Berger H, Innerhofer P (2006) Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy–a porcine model. Br J Anaesth 97:460–467

    PubMed  CAS  Google Scholar 

  82. Fries D, Streif W, Haas T, Kuhbacher G (2004) Dilutional coagulopathy, an underestimated problem? Anasthesiol Intensivmed Notfallmed Schmerzther 39:745–750

    PubMed  CAS  Google Scholar 

  83. Frim DM, Barker FG, Poletti CE, Hamilton AJ (1992) Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery 30:830–832

    PubMed  CAS  Google Scholar 

  84. Fugh-Berman A (2000) Herb-drug interactions. Lancet 355:134–138

    PubMed  CAS  Google Scholar 

  85. Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O (1994) Serial changes in hemostasis after intracranial surgery. Neurosurgery 35:26–33

    PubMed  CAS  Google Scholar 

  86. Fukamachi A, Koizumi H, Nukui H (1985) Postoperative intracerebral hemorrhages: a survey of computed tomographic findings after 1,074 intracranial operations. Surg Neurol 23:575–580

    PubMed  CAS  Google Scholar 

  87. Gando S, Nakanishi Y, Tedo I (1995) Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 23:1835–1842

    PubMed  CAS  Google Scholar 

  88. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:338S–400S

    PubMed  CAS  Google Scholar 

  89. Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De CG, Bille G, Stefano P, Gensini GF (2008) Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis. Eur J Cardiothorac Surg 33:64–71

    PubMed  Google Scholar 

  90. Gerlach R, Marquardt G, Wissing H, Scharrer I, Raabe A, Seifert V (2002) Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. Case report. J Neurosurg 96:946–948

    PubMed  Google Scholar 

  91. Gerlach R, Raabe A, Beck J, Woszczyk A, Seifert V (2004) Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J 13(1):9–13

    Google Scholar 

  92. Gerlach R, Raabe A, Scharrer I, Meixensberger J, Seifert V (2004) Post-operative hematoma after surgery for intracranial meningiomas: causes, avoidable risk factors and clinical outcome. Neurol Res 26:61–66

    PubMed  Google Scholar 

  93. Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V (2000) Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures [In Process Citation]. Surg Neurol 54:260–266

    PubMed  CAS  Google Scholar 

  94. Gerlach R, Scheuer T, Beck J, Woszczyk A, Seifert V, Raabe A (2003) Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery 53:1028–1035

    PubMed  Google Scholar 

  95. Gerlach R, Scheuer T, Bohm M, Beck J, Woszczyk A, Raabe A, Scharrer I, Seifert V (2003) Increased levels of plasma tissue factor pathway inhibitor in patients with glioblastoma and intracerebral metastases. Neurol Res 25:335–338

    PubMed  CAS  Google Scholar 

  96. Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V (2002) Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 33:1618–1623

    PubMed  Google Scholar 

  97. Gerstner T, Teich M, Bell N, Longin E, Dempfle CE, Brand J, Konig S (2006) Valproate-associated coagulopathies are frequent and variable in children. Epilepsia 47:1136–1143

    PubMed  Google Scholar 

  98. Gnanalingham KK, Holland JP (2003) Attitudes to the use of prophylaxis for thrombo-embolism in neurosurgical patients. J Clin Neurosci 10:467–469

    PubMed  Google Scholar 

  99. Goh KY, Poon WS, Chan DT, Ip CP (2005) Tissue plasminogen activator expression in meningiomas and glioblastomas. Clin Neurol Neurosurg 107:296–300

    PubMed  Google Scholar 

  100. Goh KY, Tsoi WC, Feng CS, Wickham N, Poon WS (1997) Haemostatic changes during surgery for primary brain tumours. J Neurol Neurosurg Psychiatry 63:334–338

    PubMed  CAS  Google Scholar 

  101. Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM (2002) Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 122:1933–1937

    PubMed  Google Scholar 

  102. Goldstein JN, Rosand J, Schwamm LH (2008) Warfarin reversal in anticoagulant-associated intracerebral hemorrhage. Neurocrit Care 9(2):277–283

    Google Scholar 

  103. Goobie SM, Soriano SG, Zurakowski D, McGowan FX, Rockoff MA (2001) Hemostatic changes in pediatric neurosurgical patients as evaluated by thrombelastograph. Anesth Analg 93:887–892

    PubMed  CAS  Google Scholar 

  104. Goodnight SH, Kenoyer G, Rapaport SI, Patch MJ, Lee JA, Kurze T (1974) Defibrination after brain-tissue destruction: a serious complication of head injury. N Engl J Med 290:1043–1047

    PubMed  CAS  Google Scholar 

  105. Goodnough LT (2004) Experiences with recombinant human factor VIIa in patients with thrombocytopenia. Semin Hematol 41:25–29

    PubMed  CAS  Google Scholar 

  106. Gorlinger K (2006) Coagulation management during liver transplantation. Hamostaseologie 26:S64–S76

    PubMed  CAS  Google Scholar 

  107. Gosseye S, van OL, Weynand B, Scheiff JM, Moulin D, de GJ de Ville, Otte JB (1991) Platelet aggregates in small lung vessels and death during liver transplantation. Lancet 338:532–534

    PubMed  CAS  Google Scholar 

  108. Grady RE, Oliver WC Jr, Abel MD, Meyer FB (2002) Aprotinin and deep hypothermic cardiopulmonary bypass with or without circulatory arrest for craniotomy. J Neurosurg Anesthesiol 14:137–140

    PubMed  Google Scholar 

  109. Grady RE, Oliver WC Jr, Abel MD, Meyer FB (2002) Aprotinin and deep hypothermic cardiopulmonary bypass with or without circulatory arrest for craniotomy. J Neurosurg Anesthesiol 14:137–140

    PubMed  Google Scholar 

  110. Graham DI, Adams JH (1971) Ischaemic brain damage in fatal head injuries. Lancet 1:265–266

    PubMed  CAS  Google Scholar 

  111. Graham DI, Ford I, Adams JH, Doyle D, Teasdale GM, Lawrence AE, McLellan DR (1989) Ischaemic brain damage is still common in fatal non-missile head injury. J Neurol Neurosurg Psychiatry 52:346–350

    PubMed  CAS  Google Scholar 

  112. Greenberg MS (1997) Hematology. In: Greenberg MS (ed) Handbook of neurosurgery, 4th edn. Greenberg Graphics Inc., Lakeland, Florida, pp 491–523

    Google Scholar 

  113. Grenander A, Bredbacka S, Rydvall A, Aroch R, Edner G, Koskinen LO, Olivecrona M (2001) Antithrombin treatment in patients with traumatic brain injury: a pilot study. J Neurosurg Anesthesiol 13:49–56

    PubMed  CAS  Google Scholar 

  114. Grounds M (2003) Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review. Blood Rev 17(Suppl 1):S11–S21

    PubMed  Google Scholar 

  115. Guan M, Su B, Lu Y (2002) Quantitative reverse transcription-PCR measurement of tissue factor mRNA in glioma. Mol Biotechnol 20:123–129

    PubMed  CAS  Google Scholar 

  116. Hamilton MG, Hull RD, Pineo GF (1994) Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery 34:280–96, discussion 296

    PubMed  CAS  Google Scholar 

  117. Hanley JP (2004) Warfarin reversal. J Clin Pathol 57:1132–1139

    PubMed  CAS  Google Scholar 

  118. Hansen MK, Jensen MK, Andersen C (2006) Uncontrollable bleeding in a patient with head trauma treated with blood component therapy guided by thromboelastography. Ugeskr Laeger 168:3535–3536

    PubMed  Google Scholar 

  119. Hardy JF, de Moerloose P, Samama M (2004) Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 51:293–310

    PubMed  Google Scholar 

  120. Harrison TD, Laskosky J, Jazaeri O, Pasquale MD, Cipolle M (2005) “Low-dose” recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma 59:150–154

    PubMed  CAS  Google Scholar 

  121. Hartmann M, Sucker C, Messing M (2006) Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature. J Neurosurg 104:55–58

    PubMed  Google Scholar 

  122. Hawryluk GW, Cusimano MD (2006) The role of recombinant activated factor VII in neurosurgery: hope or hype? J Neurosurg 105:859–868

    PubMed  CAS  Google Scholar 

  123. Hendriks HG, Meijer K, de Wolf JT, Klompmaker IJ, Porte RJ, de Kam PJ, Hagenaars AJ, Melsen T, Slooff MJ, der MJ van (2001) Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation 71:402–405

    PubMed  CAS  Google Scholar 

  124. Hendriks HG, Meijer K, de Wolf JT, Porte RJ, Klompmaker IJ, Lip H, Slooff MJ, van der MJ (2002) Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation. Blood Coagul Fibrinolysis 13:309–313

    PubMed  CAS  Google Scholar 

  125. Hiippala ST (1995) Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 6:743–746

    PubMed  CAS  Google Scholar 

  126. Hiippala ST, Myllyla GJ, Vahtera EM (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81:360–365

    PubMed  CAS  Google Scholar 

  127. Ho AM, Dion PW, Cheng CA, Karmakar MK, Cheng G, Peng Z, Ng YW (2005) A mathematical model for fresh-frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg 48:470–478

    PubMed  Google Scholar 

  128. Ho AM, Karmakar MK, Dion PW (2005) Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg 190:479–484

    PubMed  Google Scholar 

  129. Hoffman M, Monroe DM (2007) Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am 21:1–11

    PubMed  Google Scholar 

  130. Holland LL, Brooks JP (2006) Toward rational fresh-frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 126:133–139

    PubMed  Google Scholar 

  131. Holland LL, Foster TM, Marlar RA, Brooks JP (2005) Fresh-frozen plasma is ineffective for correcting minimally elevated international normalized ratios. Transfusion 45:1234–1235

    PubMed  Google Scholar 

  132. Holmin S, Soderlund J, Biberfeld P, Mathiesen T (1998) Intracerebral inflammation after human brain contusion. Neurosurgery 42:291–298

    PubMed  CAS  Google Scholar 

  133. Hoots WK (1997) Experience with antithrombin concentrates in neurotrauma patients. Semin Thromb Hemost 23(Suppl 1):3–16

    PubMed  Google Scholar 

  134. Hoots WK (1997) Experience with antithrombin concentrates in neurotrauma patients. Semin Thromb Hemost 23(Suppl 1):3–16

    PubMed  Google Scholar 

  135. Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S (2005) Herb-drug interactions: a literature review. Drugs 65:1239–1282

    PubMed  CAS  Google Scholar 

  136. Huber A, Dorn A, Witzmann A, Cervos-Navarro J (1993) Microthrombi formation after severe head trauma. Int J Legal Med 106:152–155

    PubMed  CAS  Google Scholar 

  137. Hulka F, Mullins RJ, Frank EH (1996) Blunt brain injury activates the coagulation process. Arch Surg 131:923–927

    PubMed  CAS  Google Scholar 

  138. Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95:858–65

    PubMed  Google Scholar 

  139. Iorio A, Agnelli G (2000) Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 160:2327–2332

    PubMed  CAS  Google Scholar 

  140. Izzo AA, Ernst E (2001) Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61:2163–2175

    PubMed  CAS  Google Scholar 

  141. Jackson WL Jr, Shorr AF (2005) Blood transfusion and the development of acute respiratory distress syndrome: more evidence that blood transfusion in the intensive care unit may not be benign. Crit Care Med 33:1420–1421

    PubMed  Google Scholar 

  142. James DN, Fernandes JR, Calder I, Smith M (1997) Low-dose aspirin and intracranial surgery. A survey of the opinions of consultant neuroanaesthetists in the UK. Anaesthesia 52:169–172

    PubMed  CAS  Google Scholar 

  143. Jamnicki M, Bombeli T, Seifert B, Zollinger A, Camenzind V, Pasch T, Spahn DR (2000) Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation. Anesthesiology 93:1231–1237

    PubMed  CAS  Google Scholar 

  144. Jellinek DA, Robin F (2000) Perioperative Care. In: Kaye Andrew H et al (eds) Operative neurosurgery. Churchill Livingston, London, pp 15–32

    Google Scholar 

  145. Jones SB, Whitten CW, Despotis GJ, Monk TG (2003) The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg 96:363–8

    PubMed  Google Scholar 

  146. Kalabalikis P, Papazoglou K, Gouriotis D, Papadopoulos N, Kardara M, Papageorgiou F, Papadatos J (1999) Correlation between serum IL-6 and CRP levels and severity of head injury in children. Intensive Care Med 25:288–292

    PubMed  CAS  Google Scholar 

  147. Kalfas IH, Little JR (1988) Postoperative hemorrhage: a survey of 4,992 intracranial procedures. Neurosurgery 23:343–347

    Article  PubMed  CAS  Google Scholar 

  148. Kapiotis S, Quehenberger P, Eichler HG, Schwarzinger I, Partan C, Schneider B, Lechner K, Speiser W (1994) Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Crit Care Med 22:606–612

    PubMed  CAS  Google Scholar 

  149. Karadimov D, Binev K, Nachkov Y, Platikanov V (2003) Use of activated recombinant factor VII (NovoSeven) during neurosurgery. J Neurosurg Anesthesiol 15:330–332

    PubMed  Google Scholar 

  150. Kaufman HH, Hui KS, Mattson JC, Borit A, Childs TL, Hoots WK, Bernstein DP, Makela ME, Wagner KA, Kahan BD (1984) Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury. Neurosurgery 15:34–42

    Article  PubMed  CAS  Google Scholar 

  151. Kaufman HH, Moake JL, Olson JD, Miner ME, duCret RP, Pruessner JL, Gildenberg PL (1980) Delayed and recurrent intracranial hematomas related to disseminated intravascular clotting and fibrinolysis in head injury. Neurosurgery 7:445–449

    Article  PubMed  CAS  Google Scholar 

  152. Kaufmann JE, Vischer UM (2003) Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 1:682–689

    PubMed  CAS  Google Scholar 

  153. Kaushal R, Bates DW, Franz C, Soukup JR, Rothschild JM (2007) Costs of adverse events in intensive care units. Crit Care Med 35:2479–2483

    PubMed  Google Scholar 

  154. Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB (2004) The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. Spine 29:1384–1387

    PubMed  Google Scholar 

  155. Kearney TJ, Bentt L, Grode M, Lee S, Hiatt JR, Shabot MM (1992) Coagulopathy and catecholamines in severe head injury. J Trauma 32:608–611

    PubMed  CAS  Google Scholar 

  156. Keimowitz RM, Annis BL (1973) Disseminated intravascular coagulation associated with massive brain injury. J Neurosurg 39:178–180

    PubMed  CAS  Google Scholar 

  157. Kenet G, Walden R, Eldad A, Martinowitz U (1999) Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354:1879

    PubMed  CAS  Google Scholar 

  158. Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore SB, Hubmayr RD, Gajic O (2007) Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 131:1308–1314

    PubMed  Google Scholar 

  159. Kis B, Szupera Z, Mezei Z, Gecse A, Telegdy G, Vecsei L (1999) Valproate treatment and platelet function: the role of arachidonate metabolites. Epilepsia 40:307–310

    PubMed  CAS  Google Scholar 

  160. Kissela BM, Eckman MH (2008) Cost-effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage. BMC Neurol 8:17

    PubMed  Google Scholar 

  161. Kleindienst A, Harvey HB, Mater E, Bronst J, Flack J, Herenz K, Haupt WF, Schon R (2003) Early antithrombotic prophylaxis with low-molecular-weight heparin in neurosurgery. Acta Neurochir (Wien) 145:1085–1090

    CAS  Google Scholar 

  162. Knudson MM, Morabito D, Paiement GD, Shackleford S (1996) Use of low-molecular-weight heparin in preventing thromboembolism in trauma patients. J Trauma 41:446–459

    PubMed  CAS  Google Scholar 

  163. Koizume S, Jin MS, Miyagi E, Hirahara F, Nakamura Y, Piao JH, Asai A, Yoshida A, Tsuchiya E, Ruf W, Miyagi Y (2006) Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Cancer Res 66:9453–9460

    PubMed  CAS  Google Scholar 

  164. Konig SA, Schick U, Dohnert J, Goldammer A, Vitzthum HE (2003) Coagulopathy and outcome in patients with chronic subdural haematoma. Acta Neurol Scand 107:110–116

    PubMed  CAS  Google Scholar 

  165. Koos W, Kraus H, Blumel G, Bock F (1970) Mode of action of proteinase inhibitors (Trasylol) in intracranial hemorrhages. Neurochirurgie 16:548–550

    PubMed  CAS  Google Scholar 

  166. Korinth MC (2006) Low-dose aspirin before intracranial surgery—results of a survey among neurosurgeons in Germany. Acta Neurochir (Wien ) 148:1189–1196

    CAS  Google Scholar 

  167. Korinth MC, Gilsbach JM, Weinzierl MR. (2007) Low-dose aspirin before spinal surgery: results of a survey among neurosurgeons in Germany. Eur Spine J 16(3):365–372

    Google Scholar 

  168. Korte W (2006) Fibrin monomer and factor XIII: a new concept for unexplained intraoperative coagulopathy. Hamostaseologie 26:S30–S35

    PubMed  CAS  Google Scholar 

  169. Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, Salama A, Kiesewetter H, Latza R (2004) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10:195–204

    PubMed  CAS  Google Scholar 

  170. Kou J, Fischgrund J, Biddinger A, Herkowitz H (2002) Risk factors for spinal epidural hematoma after spinal surgery. Spine 27:1670–1673

    PubMed  CAS  Google Scholar 

  171. Kozek-Langenecker SA (2005) Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103:654–660

    PubMed  Google Scholar 

  172. Kreuz W, Linde R, Funk M, Meyer-Schrod R, Foll E, Nowak-Gottl U, Jacobi G, Vigh Z, Scharrer I (1992) Valproate therapy induces von Willebrand disease type I. Epilepsia 33:178–184

    PubMed  CAS  Google Scholar 

  173. Kurtoglu M, Yanar H, Bilsel Y, Guloglu R, Kizilirmak S, Buyukkurt D, Granit V (2004) Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low-molecular-weight heparin. World J Surg 28:807–811

    PubMed  Google Scholar 

  174. Kushimoto S, Shibata Y, Yamamoto Y (2003) Implications of fibrinogenolysis in patients with closed head injury. J Neurotrauma 20:357–363

    PubMed  Google Scholar 

  175. Kushimoto S, Yamamoto Y, Shibata Y, Sato H, Koido Y (2001) Implications of excessive fibrinolysis and alpha(2)-plasmin inhibitor deficiency in patients with severe head injury. Neurosurgery 49:1084–1089

    PubMed  CAS  Google Scholar 

  176. Kushimoto S, Yamamoto Y, Shibata Y, Sato H, Koido Y (2001) Implications of excessive fibrinolysis and alpha(2)-plasmin inhibitor deficiency in patients with severe head injury. Neurosurgery 49:1084–1089

    PubMed  CAS  Google Scholar 

  177. Lackmann GM (2004) Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment? Pharmacology 70:57–58

    PubMed  CAS  Google Scholar 

  178. Lang T, von DM (2006) Possibilities and limitations of thrombelastometry/-graphy. Hamostaseologie 26:S20–S29

    PubMed  CAS  Google Scholar 

  179. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM (2006) Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 4:967–970

    PubMed  CAS  Google Scholar 

  180. Lawton MT, Raudzens PA, Zabramski JM, Spetzler RF (1998) Hypothermic circulatory arrest in neurovascular surgery: evolving indications and predictors of patient outcome. Neurosurgery 43:10–20

    PubMed  CAS  Google Scholar 

  181. Leithauser B, Zielske D, Seyfert UT, Jung F (2008) Effects of desmopressin on platelet membrane glycoproteins and platelet aggregation in volunteers on clopidogrel. Clin Hemorheol Microcirc 39:293–302

    PubMed  CAS  Google Scholar 

  182. Levy JH (2006) Massive transfusion coagulopathy. Semin Hematol 43:S59–S63

    PubMed  Google Scholar 

  183. Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ (2006) Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 46:919–933

    PubMed  CAS  Google Scholar 

  184. Lier H, Kampe S, Schroder S (2007) Prerequisites of a functional haemostasis. What must be considered at the scene of an accident, in the emergency room and during an operation? Anaesthesist 56:239–251

    PubMed  CAS  Google Scholar 

  185. Lillicrap D, Nair SC, Srivastava A, Rodeghiero F, Pabinger I, Federici AB (2006) Laboratory issues in bleeding disorders. Haemophilia 12(Suppl 3):68–75

    PubMed  CAS  Google Scholar 

  186. Lin J, Hanigan WC, Tarantino M, Wang J (2003) The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 98:737–740

    PubMed  CAS  Google Scholar 

  187. Lisman T, Leebeek FW, Meijer K, van der MJ, Nieuwenhuis HK, de Groot PG (2002) Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation. Hepatology 35:616–621

    PubMed  Google Scholar 

  188. Lodge JP, Jonas S, Jones RM, Olausson M, Mir-Pallardo J, Soefelt S, Garcia-Valdecasas JC, McAlister V, Mirza DF (2005) Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 11:973–979

    PubMed  Google Scholar 

  189. Lorenz R, Kienast J, Otto U, Egger K, Kiehl M, Schreiter D, Kwasny H, Haertel S, Barthels M (2003) Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol 15:15–20

    PubMed  CAS  Google Scholar 

  190. Lorenz R, Kienast J, Otto U, Kiehl M, Schreiter D, Haertel S, Barthels M (2007) Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study. Blood Coagul Fibrinolysis 18:565–570

    PubMed  CAS  Google Scholar 

  191. Lubetsky A, Hoffman R, Zimlichman R, Eldor A, Zvi J, Kostenko V, Brenner B (2004) Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation. Thromb Res 113:371–378

    PubMed  CAS  Google Scholar 

  192. Luxembourg B, Krause M, Lindhoff-Last E (2007) Blood clotting disorders. Deutsches Ärzteblatt 104:1489–1498

    Google Scholar 

  193. Lyseng-Williamson KA, Plosker GL (2007) Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX. Pharmacoeconomics 25:1007–1029

    PubMed  CAS  Google Scholar 

  194. Macdonald RL, Amidei C, Baron J, Weir B, Brown F, Erickson RK, Hekmatpanah J, Frim D (2003) Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol 59:363–372

    PubMed  Google Scholar 

  195. Macdonald RL, Amidei C, Lin G, Munshi I, Baron J, Weir BK, Brown F, Erickson RK, Hekmatpanah J (1999) Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy. Neurosurgery 45:245–251

    PubMed  CAS  Google Scholar 

  196. Macik BG, Lindley CM, Lusher J, Sawyer WT, Bloom AL, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR (1993) Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study. Blood Coagul Fibrinolysis 4:521–527

    PubMed  CAS  Google Scholar 

  197. MacLennan S, Williamson LM (2006) Risks of fresh-frozen plasma and platelets. J Trauma 60:S46–S50

    PubMed  Google Scholar 

  198. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh-frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 77:477–480

    PubMed  CAS  Google Scholar 

  199. Malham GM, Souter MJ (2001) Systemic inflammatory response syndrome and acute neurological disease. Br J Neurosurg 15:381–387

    PubMed  CAS  Google Scholar 

  200. Mangano DT, Rieves RD, Weiss KD (2006) Judging the safety of aprotinin. N Engl J Med 355:2261–2262

    PubMed  CAS  Google Scholar 

  201. Mangano DT, Tudor IC, Dietzel C (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354:353–365

    PubMed  CAS  Google Scholar 

  202. Martini WZ, Pusateri AE, Uscilowicz JM, Delgado AV, Holcomb JB (2005) Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma 58:1002–1009

    PubMed  Google Scholar 

  203. Martinowitz U, Michaelson M (2005) Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 3:640–648

    PubMed  CAS  Google Scholar 

  204. May AK, Young JS, Butler K, Bassam D, Brady W (1997) Coagulopathy in severe closed head injury: is empiric therapy warranted? Am Surg 63:233–236

    PubMed  CAS  Google Scholar 

  205. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352:777–785

    PubMed  CAS  Google Scholar 

  206. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (2008) Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358:2127–2137

    PubMed  CAS  Google Scholar 

  207. Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (2005) Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 36:74–79

    PubMed  CAS  Google Scholar 

  208. Mazer CD, Leong-Poi H, Mahoney J, Latter D, Strauss BH, Teitel JM (2007) Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa. Semin Cardiothorac Vasc Anesth 11:261–264

    PubMed  Google Scholar 

  209. McLoughlin TM, Fontana JL, Alving B, Mongan PD, Bunger R (1996) Profound normovolemic hemodilution: hemostatic effects in patients and in a porcine model. Anesth Analg 83:459–465

    PubMed  CAS  Google Scholar 

  210. Merriman E, Bell W, Long DM (1979) Surgical postoperative bleeding associated with aspirin ingestion. Report of two cases. J Neurosurg 50:682–684

    PubMed  CAS  Google Scholar 

  211. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P (2007) Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 105:905–17

    PubMed  CAS  Google Scholar 

  212. Monroe DM, Hoffman M, Roberts HR (2002) Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22:1381–1389

    PubMed  CAS  Google Scholar 

  213. Morenski JD, Tobias JD, Jimenez DF (2003) Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. Report of three cases and review of the literature. J Neurosurg 98:611–616

    PubMed  Google Scholar 

  214. Munro J, Booth A, Nicholl J (1997) Routine preoperative testing: a systematic review of the evidence. Health Technol Assess 1:i–iv

    PubMed  CAS  Google Scholar 

  215. Nakau H, Maruishi M, Takiguchi H, Shima K (1998) Successful surgical removal of a large arteriovenous malformation in a patient with hemophilia: case report. Neurosurgery 43:1459–1461

    PubMed  CAS  Google Scholar 

  216. Neilipovitz DT (2004) Tranexamic acid for major spinal surgery. Eur Spine J 13(Suppl 1):S62–S65

    PubMed  Google Scholar 

  217. Nekludov M, Bellander BM, Blomback M, Wallen HN (2007) Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma 24:1699–1706

    PubMed  Google Scholar 

  218. Niemi T, Tanskanen P, Taxell C, Juvela S, Randell T, Rosenberg P (1999) Effects of nonsteroidal anti-inflammatory drugs on hemostasis in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 11:188–194

    PubMed  CAS  Google Scholar 

  219. Ninchoji T, Uemura K, Shimoyama I, Hinokuma K, Bun T, Nakajima S (1984) Traumatic intracerebral haematomas of delayed onset. Acta Neurochir (Wien) 71:69–90

    CAS  Google Scholar 

  220. Nurmohamed MT, van Riel AM, Henkens CM, Koopman MM, Que GT, d’Azemar P, Buller HR, ten Cate JW, Hoek JA, van der MJ, van der HC, Turpie AG, Haley S, Sicurella A, Gent M (1996) low-molecular-weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost 75:233–238

    PubMed  CAS  Google Scholar 

  221. O’Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM (2006) Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295:293–298

    PubMed  Google Scholar 

  222. Oertel M, Kelly DF, McArthur D, Boscardin WJ, Glenn TC, Lee JH, Gravori T, Obukhov D, McBride DQ, Martin NA (2002) Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J Neurosurg 96:109–116

    PubMed  Google Scholar 

  223. Olson JD, Kaufman HH, Moake J, O’Gorman TW, Hoots K, Wagner K, Brown CK, Gildenberg PL (1989) The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery 24:825–832

    PubMed  CAS  Google Scholar 

  224. Ostermann H, Haertel S, Knaub S, Kalina U, Jung K, Pabinger I (2007) Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers. Thromb Haemost 98:790–797

    PubMed  CAS  Google Scholar 

  225. Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H (2008) Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 6:622–631

    PubMed  CAS  Google Scholar 

  226. Palmer JD, Francis DA, Roath OS, Francis JL, Iannotti F (1995) Hyperfibrinolysis during intracranial surgery: effect of high dose aprotinin. J Neurol Neurosurg Psychiatry 58:104–106

    PubMed  CAS  Google Scholar 

  227. Palmer JD, Francis JL, Pickard JD, Iannotti F (2003) The efficacy and safety of aprotinin for hemostasis during intracranial surgery. J Neurosurg 98:1208–1216

    PubMed  CAS  Google Scholar 

  228. Palmer JD, Sparrow OC, Iannotti F (1994) Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 35:1061–1064

    PubMed  CAS  Google Scholar 

  229. Parameswaran R, Shapiro AD, Gill JC, Kessler CM (2005) Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry. Haemophilia 11:100–106

    PubMed  CAS  Google Scholar 

  230. Park P, Fewel ME, Garton HJ, Thompson BG, Hoff JT (2003) Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery 53:34–38

    PubMed  Google Scholar 

  231. Pathak A, Dutta S, Marwaha N, Singh D, Varma N, Mathuriya SN (2005) Change in tissue thromboplastin content of brain following trauma. Neurol India 53:178–182

    Article  PubMed  CAS  Google Scholar 

  232. Pernod G, Barro C, Arnutti B, Blanc-Jouvan F, Garrel S, Kahn P, Minotti L, Koudsie A, Benabid AL, Wrobleski I, Joannard A, Polack B (2003) Surgery in severe factor XIII deficiency: report of a case of epilepsy neurosurgery and review. Haemophilia 9:121–124

    PubMed  CAS  Google Scholar 

  233. Pfanner G, Koscielny J, Pernerstorfer T, Gutl M, Perger P, Fries D, Hofmann N, Innerhofer P, Kneifl W, Neuner L, Schochl H, Kozek-Langenecker SA (2007) Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care. Anaesthesist 56:604–611

    PubMed  CAS  Google Scholar 

  234. Pickard JD, Kirkpatrick PJ, Melsen T, Andreasen RB, Gelling L, Fryer T, Matthews J, Minhas P, Hutchinson PJ, Menon D, Downey SP, Kendall I, Clark J, Carpenter TA, Williams E, Persson L (2000) Potential role of NovoSeven in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage. Blood Coagul Fibrinolysis 11(Suppl 1):S117–20 S117-S120

    PubMed  CAS  Google Scholar 

  235. Piek J, Chesnut RM, Marshall LF, Berkum-Clark M, Klauber MR, Blunt BA, Eisenberg HM, Jane JA, Marmarou A, Foulkes MA (1992) Extracranial complications of severe head injury. J Neurosurg 77:901–907

    PubMed  CAS  Google Scholar 

  236. Planinsic RM, van der MJ, Testa G, Grande L, Candela A, Porte RJ, Ghobrial RM, Isoniemi H, Schelde PB, Erhardtsen E, Klintmalm G, Emre S (2005) Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 11:895–900

    PubMed  Google Scholar 

  237. Pohlmann-Eden B, Peters CN, Wennberg R, Dempfle CE (2003) Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding. Acta Neurol Scand 108:142–145

    PubMed  CAS  Google Scholar 

  238. Pondaag W (1979) Disseminated intravascular coagulation related to outcome in head injury. Acta Neurochir Suppl (Wien) 28:98–102

    CAS  Google Scholar 

  239. Powner DJ, Hartwell EA, Hoots WK (2005) Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies. Neurosurgery 57:823–831

    PubMed  Google Scholar 

  240. Prasad KS, Sharma BS, Marwaha N, Sarode RS, Kak VK (1994) Haemostatic derangement in patients with intracranial tumours. Br J Neurosurg 8:695–702

    PubMed  CAS  Google Scholar 

  241. Preston FE, Laidlaw ST, Sampson B, Kitchen S (2002) Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 116:619–624

    PubMed  CAS  Google Scholar 

  242. Raabe A, Beck J, Keller M, Vatter H, Zimmermann M, Seifert V (2005) Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 103:974–981

    PubMed  Google Scholar 

  243. Raabe A, Gerlach R, Zimmermann M, Seifert V (2000) Practice of perioperative thromboembolic prophylaxis in neurosurgery: results of a German survey. Zentralbl Neurochir 61:103–110

    PubMed  CAS  Google Scholar 

  244. Raabe A, Gerlach R, Zimmermann M, Seifert V (2001) The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir (Wien) 143:1–7

    CAS  Google Scholar 

  245. Ranucci M, Isgro G, Soro G, Conti D, De TB (2008) Efficacy and safety of recombinant activated factor vii in major surgical procedures: systematic review and meta-analysis of randomized clinical trials. Arch Surg 143:296–304

    PubMed  CAS  Google Scholar 

  246. Rao JS, Rayford A, Morantz RA, Festoff BW, Sawaya R (1993) Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumors. J Neurooncol 17:215–221

    PubMed  CAS  Google Scholar 

  247. Rebulla P (2001) Platelet transfusion trigger in difficult patients. Transfus Clin Biol 8:249–254

    PubMed  CAS  Google Scholar 

  248. Reinhofer M, Brauer M, Franke U, Barz D, Marx G, Losche W (2008) The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 19:212–219

    PubMed  Google Scholar 

  249. Resnick DK, Marion DW, Darby JM (1994) The effect of hypothermia on the incidence of delayed traumatic intracerebral hemorrhage. Neurosurgery 34:252–255

    PubMed  CAS  Google Scholar 

  250. Reymond MA, Marbet G, Radu EW, Gratzl O (1992) Aspirin as a risk factor for hemorrhage in patients with head injuries. Neurosurg Rev 15:21–25

    PubMed  CAS  Google Scholar 

  251. Richards PG, Marath A, Edwards JM, Lincoln C (1987) Management of difficult intracranial aneurysms by deep hypothermia and elective cardiac arrest using cardiopulmonary bypass. Br J Neurosurg 1:261–269

    PubMed  CAS  Google Scholar 

  252. Riess HB, Meier-Hellmann A, Motsch J, Elias M, Kursten FW, Dempfle CE (2007) Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res 121:9–16

    PubMed  CAS  Google Scholar 

  253. Rizoli SB (2003) Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate. J Trauma 54:S82–S88

    PubMed  Google Scholar 

  254. Rodas RA, Fenstermaker RA, McKeever PE, Blaivas M, Dickinson LD, Papadopoulos SM, Hoff JT, Hopkins LN, Duffy-Fronckowiak M, Greenberg HS (1998) Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: a preliminary report. J Neurosurg 89:200–205

    PubMed  CAS  Google Scholar 

  255. Rodeghiero F, Castaman G (2005) Treatment of von Willebrand disease. Semin Hematol 42:29–35

    PubMed  CAS  Google Scholar 

  256. Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, Mucksavage J, Tesoro E (2005) Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study. Neurosurgery 57:832–836

    PubMed  Google Scholar 

  257. Rong Y, Durden DL, Van Meir EG, Brat DJ (2006) 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65:529–539

    PubMed  Google Scholar 

  258. Rong Y, Hu F, Huang R, Mackman N, Horowitz JM, Jensen RL, Durden DL, Van Meir EG, Brat DJ (2006) Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res 66:7067–7074

    PubMed  CAS  Google Scholar 

  259. Saito N, Yamazaki M, Kobayashi S, Teramoto A (2006) Resection of arteriovenous malformation in a patient with hemophilia type A. Neurol Med Chir (Tokyo) 46:191–193

    Google Scholar 

  260. Samama CM (2004) Aprotinin and major orthopedic surgery. Eur Spine J 13(Suppl 1):S56–S61

    PubMed  Google Scholar 

  261. Samama CM, Djoudi R, Lecompte T, Nathan-Denizot N, Schved JF (2005) Perioperative platelet transfusion: recommendations of the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSaPS) 2003. Can J Anaesth 52:30–37

    PubMed  Google Scholar 

  262. Sawaya R, Cummins CJ, Kornblith PL (1984) Brain tumors and plasmin inhibitors. Neurosurgery 15:795–800

    Article  PubMed  CAS  Google Scholar 

  263. Sawaya R, Ramo OJ, Glas-Greenwalt P, Wu SZ (1991) Plasma fibrinolytic profile in patients with brain tumors. Thromb Haemost 65:15–19

    PubMed  CAS  Google Scholar 

  264. Sawaya R, Zuccarello M, Elkalliny M, Nishiyama H (1992) Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile. J Neurooncol 14:119–125

    PubMed  CAS  Google Scholar 

  265. Scharbert G, Gebhardt K, Sow Z, Duris M, Deusch E, Kozek-Langenecker S (2007) Point-of-care platelet function tests: detection of platelet inhibition induced by nonopioid analgesic drugs. Blood Coagul Fibrinolysis 18:775–780

    PubMed  CAS  Google Scholar 

  266. Schuster R, Waxman K (2005) Is repeated head computed tomography necessary for traumatic intracranial hemorrhage? Am Surg 71:701–704

    PubMed  Google Scholar 

  267. Sciacca FL, Ciusani E, Silvani A, Corsini E, Frigerio S, Pogliani S, Parati E, Croci D, Boiardi A, Salmaggi A (2004) Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Clin Cancer Res 10:1312–1317

    PubMed  CAS  Google Scholar 

  268. Selladurai BM, Vickneswaran M, Duraisamy S, Atan M (1997) Coagulopathy in acute head injury–a study of its role as a prognostic indicator. Br J Neurosurg 11:398–404

    PubMed  CAS  Google Scholar 

  269. Semrad TJ, O'Donnell R, Wun T, Chew H, Harvey D, Zhou H, White RH (2007) Epidemiology of venous thromboembolism in 9,489 patients with malignant glioma. J Neurosurg 106:601–608

    PubMed  Google Scholar 

  270. Serdaroglu G, Tutuncuoglu S, Kavakli K, Tekgul H (2002) Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid. J Child Neurol 17:41–43

    PubMed  Google Scholar 

  271. Seremetis S (2003) Dose optimization of recombinant factor VIIa in the treatment of acute bleeding in haemophilia-associated inhibitors. Blood Coagul Fibrinolysis 14(Suppl 1):S29–S30

    PubMed  CAS  Google Scholar 

  272. Shander A (2007) Financial and clinical outcomes associated with surgical bleeding complications. Surgery 142:S20–S25

    PubMed  Google Scholar 

  273. Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR (2007) Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 21:271–289

    PubMed  Google Scholar 

  274. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA (1998) Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 80:773–778

    PubMed  CAS  Google Scholar 

  275. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA (1999) Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88:312–319

    PubMed  CAS  Google Scholar 

  276. Singbartl K, Innerhofer P, Radvan J, Westphalen B, Fries D, Stogbauer R, Van AH (2003) Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesth Analg 96:929–35

    PubMed  Google Scholar 

  277. Singh VP, Jain D, Mohan R, Bhatia R, Bhargava M (1990) Haemostatic abnormalities in brain tumours. Acta Neurochir (Wien) 102:103–107

    CAS  Google Scholar 

  278. Smith SF, Simpson JM, Sekhon LH (2004) Prophylaxis for deep venous thrombosis in neurosurgical oncology: review of 2779 admissions over a 9-year period. Neurosurg Focus 17:E4

    PubMed  Google Scholar 

  279. Sorensen B, Ingerslev J (2004) Thromboelastography and recombinant factor VIIa-hemophilia and beyond. Semin Hematol 41:140–144

    PubMed  CAS  Google Scholar 

  280. Sorensen B, Ingerslev J (2005) Tailoring haemostatic treatment to patient requirements—an update on monitoring haemostatic response using thrombelastography. Haemophilia 11(Suppl 1):1–6

    PubMed  Google Scholar 

  281. Sorensen B, Ingerslev J (2006) A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate. Thromb Haemost 96:446–453

    PubMed  Google Scholar 

  282. Sorensen B, Johansen P, Nielsen GL, Sorensen JC, Ingerslev J (2003) Reversal of the international normalized ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 14:469–477

    PubMed  CAS  Google Scholar 

  283. Sorimachi T, Fujii Y, Morita K, Tanaka R (2005) Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage. Neurosurgery 57:837–844

    PubMed  Google Scholar 

  284. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Gordini G, Stahel PF, Hunt BJ, Komadina R, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R (2007) Management of bleeding following major trauma: a European guideline. Crit Care 11:R17

    PubMed  Google Scholar 

  285. Spahn DR, Rossaint R (2005) Coagulopathy and blood component transfusion in trauma. Br J Anaesth 95:130–139

    PubMed  CAS  Google Scholar 

  286. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM (2007) Cost reduction of perioperative coagulation management in cardiac surgery: value of “bedside” thrombelastography (ROTEM). Eur J Cardiothorac Surg 31:1052–1057

    PubMed  Google Scholar 

  287. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, Murkin J, Nadel A (2004) Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44:1143–1148

    PubMed  Google Scholar 

  288. Squizzato A, Ageno W (2007) Recombinant activated factor VII as a general haemostatic agent: evidence-based efficacy and safety. Current Drug Safety 2:155–161

    PubMed  CAS  Google Scholar 

  289. Stanworth SJ (2007) The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program 2007:179–186

    Google Scholar 

  290. Stanworth SJ, Birchall J, Doree CJ, Hyde C (2007) Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev: CD005011

  291. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF (2004) Is fresh-frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 126:139–152

    PubMed  CAS  Google Scholar 

  292. Steen CK, Astermark J, Donfield S, Berntorp E (2008) Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor. Thromb Haemost 99:1060–1067

    Google Scholar 

  293. Stein SC, Chen XH, Sinson GP, Smith DH (2002) Intravascular coagulation: a major secondary insult in nonfatal traumatic brain injury. J Neurosurg 97:1373–1377

    PubMed  Google Scholar 

  294. Stein SC, Graham DI, Chen XH, Smith DH (2004) Association between intravascular microthrombosis and cerebral ischemia in traumatic brain injury. Neurosurgery 54:687–691

    PubMed  Google Scholar 

  295. Stein SC, Smith DH (2004) Coagulopathy in traumatic brain injury. Neurocrit Care 1:479–488

    PubMed  Google Scholar 

  296. Stein SC, Smith DH (2004) Coagulopathy in traumatic brain injury. Neurocrit Care 1:479–488

    PubMed  Google Scholar 

  297. Stein SC, Spettell C, Young G, Ross SE (1993) Delayed and progressive brain injury in closed-head trauma: radiological demonstration. Neurosurgery 32:25–30

    PubMed  CAS  Google Scholar 

  298. Stein SC, Spettell CM (1995) Delayed and progressive brain injury in children and adolescents with head trauma. Pediatr Neurosurg 23:299–304

    PubMed  CAS  Google Scholar 

  299. Stein SC, Young GS, Talucci RC, Greenbaum BH, Ross SE (1992) Delayed brain injury after head trauma: significance of coagulopathy. Neurosurgery 30:160–165

    PubMed  CAS  Google Scholar 

  300. Steiner ME, Despotis GJ (2007) Transfusion algorithms and how they apply to blood conservation: the high-risk cardiac surgical patient. Hematol Oncol Clin North Am 21:177–184

    PubMed  Google Scholar 

  301. Stephens PH, Healy MT, Smith M, Jewkes DA (1995) Prophylaxis against thromboembolism in neurosurgical patients: a survey of current practice in the United Kingdom. Br J Neurosurg 9:159–163

    PubMed  CAS  Google Scholar 

  302. Stratmann G, Russell IA, Merrick SH (2003) Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair. Ann Thorac Surg 76:2094–2097

    PubMed  Google Scholar 

  303. Sugg RM, Gonzales NR, Matherne DE, Ribo M, Shaltoni HM, Baraniuk S, Noser EA, Grotta JC (2006) Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology 67:1053–1055

    PubMed  CAS  Google Scholar 

  304. Taketomi T, Szlam F, Levy JH, Tanaka KA (2008) Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII. Blood Coagul Fibrinolysis 19:106–108

    PubMed  Google Scholar 

  305. Tanaka KA, Szlam F, Dickneite G, Levy JH (2008) Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res 122:117–123

    PubMed  CAS  Google Scholar 

  306. Tanaka KA, Taketomi T, Szlam F, Calatzis A, Levy JH (2008) Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg 106:732–8

    PubMed  CAS  Google Scholar 

  307. Taylor WA, Thomas NW, Wellings JA, Bell BA (1995) Timing of postoperative intracranial hematoma development and implications for the best use of neurosurgical intensive care [see comments]. J Neurosurg 82:48–50

    PubMed  CAS  Google Scholar 

  308. Teasdale GM, Pettigrew LE, Wilson JT, Murray G, Jennett B (1998) Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma 15:587–597

    PubMed  CAS  Google Scholar 

  309. Teich M, Longin E, Dempfle CE, Konig S (2004) Factor XIII deficiency associated with valproate treatment. Epilepsia 45:187–189

    PubMed  Google Scholar 

  310. Thoron L, Arbit E (1994) Hemostatic changes in patients with brain tumors. J Neurooncol 22:87–100

    PubMed  CAS  Google Scholar 

  311. Toth O, Calatzis A, Penz S, Losonczy H, Siess W (2006) Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 96:781–788

    PubMed  CAS  Google Scholar 

  312. Treib J, Haass A, Pindur G (1997) Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 78:974–983

    PubMed  CAS  Google Scholar 

  313. Treib J, Haass A, Pindur G, Grauer MT, Jung F, Wenzel E, Schimrigk K (1997) Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch. Arzneimittelforschung 47:18–22

    PubMed  CAS  Google Scholar 

  314. Treib J, Haass A, Pindur G, Grauer MT, Treib W, Wenzel E, Schimrigk K (1996) Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases. Arzneimittelforschung 46:1064–1066

    PubMed  CAS  Google Scholar 

  315. Treib J, Haass A, Pindur G, Grauer MT, Wenzel E, Schimrigk K (1996) Decrease of fibronectin following repeated infusion of highly substituted hydroxyethyl starch. Infusionsther Transfusionsmed 23:71–75

    PubMed  CAS  Google Scholar 

  316. Treib J, Haass A, Pindur G, Miyachita C, Grauer MT, Jung F, Wenzel E, Schimrigk K (1996) Highly substituted hydroxyethyl starch (HES200/0.62) leads to Type-I von Willebrand syndrome after repeated administration. Haemostasis 26:210–213

    PubMed  CAS  Google Scholar 

  317. Treib J, Haass A, Pindur G, Treib W, Wenzel E, Schimrigk K (1996) Influence of intravascular molecular weight of hydroxyethyl starch on platelets. Eur J Haematol 56:168–172

    Article  PubMed  CAS  Google Scholar 

  318. Trowbridge CC, Stammers AH, Ciccarelli N, Klayman M (2006) Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review. J Extra Corpor Technol 38:254–259

    PubMed  Google Scholar 

  319. Turpie AG, Hirsh J, Gent M, Julian D, Johnson J (1989) Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med 149:679–681

    PubMed  CAS  Google Scholar 

  320. Ucar HI, Oc M, Tok M, Dogan OF, Oc B, Aydin A, Farsak B, Guvener M, Yorgancioglu AG, Dogan R, Demircin M, Pasaoglu I (2007) Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery. Heart Surg Forum 10:E392–E396

    PubMed  Google Scholar 

  321. Utter GH, Owings JT, Jacoby RC, Gosselin RC, Paglieroni TG (2002) Injury induces increased monocyte expression of tissue factor: factors associated with head injury attenuate the injury-related monocyte expression of tissue factor. J Trauma 52:1071–1077

    PubMed  CAS  Google Scholar 

  322. van der Sande JJ, Veltkamp JJ, Boekhout-Mussert RJ, Bouwhuis-Hoogerwerf ML (1978) Head injury and coagulation disorders. J Neurosurg 49:357–365

    PubMed  Google Scholar 

  323. Vavilala MS, Dunbar PJ, Rivara FP, Lam AM (2001) Coagulopathy predicts poor outcome following head injury in children less than 16 years of age. J Neurosurg Anesthesiol 13:13–18

    PubMed  CAS  Google Scholar 

  324. Vecht CJ, Sibinga CT, Minderhoud JM (1975) Disseminated intravascular coagulation and head injury. J Neurol Neurosurg Psychiatry 38:567–571

    PubMed  CAS  Google Scholar 

  325. Velik-Salchner C, Haas T, Innerhofer P, Streif W, Nussbaumer W, Klingler A, Klima G, Martinowitz U, Fries D (2007) The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 5:1019–1025

    PubMed  CAS  Google Scholar 

  326. Veshchev I, Elran H, Salame K (2002) Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma. Med Sci Monit 8:CS98–100

    PubMed  Google Scholar 

  327. Vigue B, Ract C, Tremey B, Engrand N, Leblanc PE, Decaux A, Martin L, Benhamou D (2007) Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage. Intensive Care Med 33:721–725

    PubMed  CAS  Google Scholar 

  328. Wallis JP, Dzik S (2004) Is fresh-frozen plasma overtransfused in the United States? Transfusion 44:1674–1675

    PubMed  Google Scholar 

  329. Weber AA, Adamzik M, Bachmann HS, Gorlinger K, Grandoch M, Leineweber K, Muller-Beissenhirtz H, Wenzel F, Naber C (2008) Methods to evaluate the pharmacology of oral antiplatelet drugs. Herz 33:287–296

    PubMed  Google Scholar 

  330. Weber CF, Jambor C, Marquardt M, Gorlinger K, Zwissler B (2008) Thrombelastometric detection of factor XIII deficiency. Anaesthesist 57:487–490

    PubMed  CAS  Google Scholar 

  331. Wen DY, Hall WA (1998) Complications of subcutaneous low-dose heparin therapy in neurosurgical patients. Surg Neurol 50:521–525

    PubMed  CAS  Google Scholar 

  332. Wettstein P, Haeberli A, Stutz M, Rohner M, Corbetta C, Gabi K, Schnider T, Korte W (2004) Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 99:1564–1569

    PubMed  CAS  Google Scholar 

  333. Yamaki T, Hirakawa K, Ueguchi T, Tenjin H, Kuboyama T, Nakagawa Y (1990) Chronological evaluation of acute traumatic intracerebral haematoma. Acta Neurochir (Wien) 103:112–115

    CAS  Google Scholar 

  334. Yokota H, Naoe Y, Nakabayashi M, Unemoto K, Kushimoto S, Kurokawa A, Node Y, Yamamoto Y (2002) Cerebral endothelial injury in severe head injury: the significance of measurements of serum thrombomodulin and the von Willebrand factor. J Neurotrauma 19:1007–1015

    PubMed  Google Scholar 

  335. Zetterling M, Ronne-Engstrom E (2004) High intraoperative blood loss may be a risk factor for postoperative hematoma. J Neurosurg Anesthesiol 16:151–155

    PubMed  Google Scholar 

Download references

Acknowledgements

We thank Marina Eberhardt, Department of Neurosurgery Johann Wolfgang Goethe- University Frankfurt/Main for her valuable contribution in preparing the figures.

Financial disclosure

None of the authors has any financial interest in the methodology being advanced with the publication of our manuscript. The authors Ruediger Gerlach* and Klaus Goerlinger** point out that they held several scientific lectures on fee basis for the following companies: CSL Behring (*;**) GmbH (Marburg, Germany), Instrumentation Laboratory (**) (Kirchheim, Germany), Novo Nordisk Pharma GmbH (*;**)(Mainz, Germany), Pentapharm GmbH (**)(Munich, Germany). Content and presentation of the publication has not been influence by these associations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruediger Gerlach.

Additional information

Comment

This is a major and very up-to-date overview about hemostatic and hemorrhagic disorders and problems encountered in neurosurgical disease and procedures. It also covers very nicely the postoperative problems, for example in the ICU, and gives clues for preoperative easy evaluation. It may turn out to become a very valuable reference paper in neurosurgical wards, with guidelines highlighted on plastic cards for daily use. Very recent developments are also covered, like the use of rF VII, including costs and cost-effectiveness. The authors give strong arguments for the routine use of modern test equipment like the ROTEM and the Multiplate test. In the subchapters, the reader can find all the necessary information on most if not all details one should like to know about specific situations. The bottom line is: the variety in the clotting and its disturbances is large, and the right tests should be used for the right things. Recommendable, especially for the education and training of residents, and not only in neurosurgery!

Janjakob Mooij

Academische Ziekenhuis Groningen,

Netherlands

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerlach, R., Krause, M., Seifert, V. et al. Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochir 151, 873–900 (2009). https://doi.org/10.1007/s00701-009-0409-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-009-0409-z

Keywords

Navigation